Dendritic Cell Immunotherapy Versus Best Supportive Care as Maintenance Treatment in Patients with Pleural Mesothelioma

被引：0
|
作者：
Aerts, J. G. J. V. [1 ]
Belderbos, B. [2 ]
Baas, P. [3 ]
Scherpereel, A. [4 ]
Berardi, R. [5 ]
Fennell, D. [6 ]
Kerstens, R. [7 ]
Cornelissen, R. [8 ]
van Meerbeeck, J. [9 ]
机构：
[1] Erasmus MC, Rotterdam, Netherlands
[2] Erasmus MC, Rotterdam, Netherlands
[3] Netherlands Canc Inst, Amsterdam, Netherlands
[4] Univ Lille, Lille, France
[5] Univ Ancona, Ancona, Italy
[6] Univ LEicester, Leicester, Leics, England
[7] Orion Stat, sHertogenbosch, Netherlands
[8] Erasmus MC Univ Hosp, Rotterdam, Netherlands
[9] Univ Hosp Ghent, Pulm Med, Ghent, Belgium
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
mesothelioma; immunotherapy; dendritic cell;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA02-05
引用
收藏
页码：S47 / S48
页数：2
相关论文
共 50 条
  • [1] Secondline Chemotherapy Versus Best Supportive Care in Patient with Malignant Pleural Mesothelioma: A Retrospective Study
    Mutlu, Hasan
    Buyukcelik, Abdullah
    Karaca, Halit
    Aksahin, Arzu
    Berk, Veli
    Aslan, Tuncay
    Erden, Abdulsamet
    Akca, Zeki
    Ozkan, Metin
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (06) : 3887 - 3889
  • [2] Chemotherapy Versus Supportive Care for Unresected Malignant Pleural Mesothelioma
    Verma, Vivek
    Wegner, Rodney E.
    Brooks, Eric D.
    Miccio, Joseph A.
    Nann, Benjamin H.
    Finley, Gene G.
    Itaj, Moses S.
    Grover, Surbhi
    Mohindra, Pranshu
    Simone, Charles B., II
    CLINICAL LUNG CANCER, 2019, 20 (04) : 263 - 269
  • [3] Dendritic cell-based immunotherapy for malignant pleural mesothelioma
    Hegmans, J.
    Hemmes, A.
    Aerts, J.
    Hoogsteden, H.
    Lambrecht, B.
    LUNG CANCER, 2006, 54 : S13 - S13
  • [4] Dendritic cell-based immunotherapy for malignant pleural mesothelioma
    Aerts, Joachim G.
    Veltman, Joris
    Lambers, Margaretha
    Lambrecht, Bart N.
    Hoogsteden, Henk C.
    Hegmans, Joost J.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S750 - S750
  • [5] Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma
    Jassem, Jacek
    Ramlau, Rodryg
    Santoro, Armando
    Schuette, Wolfgang
    Chemaissani, Assad
    Hong, Shengyan
    Blatter, Johannes
    Adachi, Susumu
    Hanauske, Axel
    Manegold, Christian
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) : 1698 - 1704
  • [6] Extrapleural pneumonectomy or supportive care: treatment of malignant pleural mesothelioma?
    Sharif, Sumera
    Zahid, Imran
    Routledge, Tom
    Scarci, Marco
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2011, 12 (06) : 1040 - 1045
  • [7] A retrospective analysis comparing APCEDEN® dendritic cell immunotherapy with best supportive care in refractory cancer
    Kumar, Chaitanya
    Kohli, Sakshi
    Chiliveru, Srikanth
    Bapsy, Poonamalle Parthasarathy
    Jain, Minish
    Attili, Venkata Sathya Suresh
    Mohan, Jagan
    Vaid, Ashok K.
    Sharan, Bandana
    IMMUNOTHERAPY, 2017, 9 (11) : 889 - 897
  • [8] Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma
    Green, J.
    Dundar, Y.
    Dodd, S.
    Dickson, R.
    Walley, T.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01):
  • [9] The Role of Immunotherapy in the Treatment of Malignant Pleural Mesothelioma
    Banerji, Shantanu
    Meyers, Daniel E.
    Harlos, Craig
    Dawe, David E.
    CURRENT ONCOLOGY, 2021, 28 (06) : 4542 - 4551
  • [10] A cost-effectiveness analysis of avelumab plus best supportive care versus best supportive care alone as first-line maintenance treatment for patients with locally advanced or metastatic urothelial carcinoma in Taiwan
    Su, Po-Jung
    Xiao, Ying
    Lin, Amy Y.
    Goh, Connie
    Wu, Ethan
    Liu, Kevin
    Chou, Patrick
    Kuo, Kaitlin
    Palencia, Roberto
    Chang, Jane
    Kearney, Mairead
    Kapetanakis, Venediktos
    Benedict, Agnes
    CANCER REPORTS, 2023,
12345